Northern Trust’s Champions Oncology CSBR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$396K Sell
53,762
-200
-0.4% -$1.47K ﹤0.01% 3724
2025
Q1
$468K Sell
53,962
-32
-0.1% -$278 ﹤0.01% 3598
2024
Q4
$463K Buy
53,994
+12,923
+31% +$111K ﹤0.01% 3684
2024
Q3
$200K Buy
41,071
+608
+2% +$2.96K ﹤0.01% 3895
2024
Q2
$209K Sell
40,463
-2,226
-5% -$11.5K ﹤0.01% 3853
2024
Q1
$209K Sell
42,689
-2,228
-5% -$10.9K ﹤0.01% 3883
2023
Q4
$252K Buy
44,917
+13,897
+45% +$78.1K ﹤0.01% 3803
2023
Q3
$193K Sell
31,020
-277
-0.9% -$1.72K ﹤0.01% 3824
2023
Q2
$200K Buy
31,297
+2,511
+9% +$16K ﹤0.01% 3834
2023
Q1
$116K Buy
28,786
+673
+2% +$2.71K ﹤0.01% 4048
2022
Q4
$127K Buy
28,113
+46
+0.2% +$207 ﹤0.01% 4016
2022
Q3
$210K Buy
28,067
+762
+3% +$5.7K ﹤0.01% 3853
2022
Q2
$218K Sell
27,305
-128
-0.5% -$1.02K ﹤0.01% 3886
2022
Q1
$223K Sell
27,433
-43
-0.2% -$350 ﹤0.01% 4092
2021
Q4
$230K Sell
27,476
-392
-1% -$3.28K ﹤0.01% 4146
2021
Q3
$285K Buy
27,868
+149
+0.5% +$1.52K ﹤0.01% 4012
2021
Q2
$285K Sell
27,719
-61,224
-69% -$629K ﹤0.01% 3964
2021
Q1
$1.01M Sell
88,943
-18,318
-17% -$207K ﹤0.01% 3584
2020
Q4
$1.16M Sell
107,261
-4,405
-4% -$47.6K ﹤0.01% 3462
2020
Q3
$1.03M Buy
111,666
+54,388
+95% +$503K ﹤0.01% 3380
2020
Q2
$548K Buy
57,278
+29,931
+109% +$286K ﹤0.01% 3531
2020
Q1
$203K Hold
27,347
﹤0.01% 3681
2019
Q4
$227K Buy
27,347
+402
+1% +$3.34K ﹤0.01% 3750
2019
Q3
$152K Sell
26,945
-1,100
-4% -$6.21K ﹤0.01% 3826
2019
Q2
$220K Hold
28,045
﹤0.01% 3793
2019
Q1
$275K Buy
28,045
+315
+1% +$3.09K ﹤0.01% 3699
2018
Q4
$217K Buy
27,730
+2,028
+8% +$15.9K ﹤0.01% 3774
2018
Q3
$449K Buy
+25,702
New +$449K ﹤0.01% 3660